Found the pdf though. Thanks stef seems very promising.
38% at the end of thereapy or a few years after ?
hbe neg more than pos I always thought its more possible on hbe-
Never heared any of the speakers speaking about the HBV and it says Paris hepitatis conference..hmm!
interesting new data on pegintf mono study:
hbeag pos
hbsag at 12weeks below 1500iu/ml can have an hbsag loss on 16% patients
hbeag neg
hbsag at 12weeks below 1500iu/ml can have an hbsag loss on 38% patients